The results of a meta-analysis conducted by Ilidromiti et al. suggest that in combination with maternal characteristics, blood adiponectin, as a known predictor of insulin resistance status, could indeed be used to evaluate the risk of GDM [77]. Here, ADIPOQ is linked to gestational diabetes.